Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial

Objectives. Periodontitis is characterized by inflammatory destruction of periodontal tissue, loss of attachment, and bone resorption. The increase in reactive oxygen species (ROS) is responsible for the oxidative damage occurring in periodontal tissues. Melatonin has important immunomodulatory, ant...

Full description

Saved in:
Bibliographic Details
Main Authors: Enji Ahmed, Olfat G. Shaker, Nermin Yussif, Dalia M. Ghalwash
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Dentistry
Online Access:http://dx.doi.org/10.1155/2021/8840167
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566037840658432
author Enji Ahmed
Olfat G. Shaker
Nermin Yussif
Dalia M. Ghalwash
author_facet Enji Ahmed
Olfat G. Shaker
Nermin Yussif
Dalia M. Ghalwash
author_sort Enji Ahmed
collection DOAJ
description Objectives. Periodontitis is characterized by inflammatory destruction of periodontal tissue, loss of attachment, and bone resorption. The increase in reactive oxygen species (ROS) is responsible for the oxidative damage occurring in periodontal tissues. Melatonin has important immunomodulatory, anti-inflammatory, and powerful antioxidant functions. The current study was carried out to evaluate the effect of topical melatonin gel as an adjunct to nonsurgical periodontal therapy. Methods. This split-mouth randomized controlled clinical trial was performed on 24 patients with grade II periodontitis. Two sites in each patient were randomly assigned; test sites were treated by nonsurgical therapy followed by intrapocket application of 5% melatonin gel. Control sites were treated by nonsurgical therapy followed by intrapocket application of placebo gel. Both the melatonin and placebo gel were applied weekly once for four weeks. Assessment of clinical parameters (PD and CAL) was done at baseline and 3 months after therapy. Total antioxidative capacity (TAC) and matrix metalloproteinase-9 (MMP-9) levels in GCF were also evaluated utilizing commercially available enzyme-linked immunosorbent assay kits (ELISA) at baseline and 3 months after therapy. Results. Treatment with topical melatonin was associated with a reduction in periodontal inflammation reflected as an improvement in the clinical periodontal parameters. Melatonin-treated sites showed a more statistically significant percent reduction in PD and more statistically significant percent gain in CAL than the control site. Additionally, a significant increase in TAC and a significant decrease in MMP-9 levels in GCF were found in melatonin-treated sites in comparison to control sites. Conclusions. The adjunctive use of topical melatonin gel with nonsurgical periodontal therapy has potent anti-inflammatory and antioxidant activity in the treatment of grade II periodontitis patients.
format Article
id doaj-art-fd1ecd1c9b2740959f7a98219333f686
institution Kabale University
issn 1687-8728
1687-8736
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Dentistry
spelling doaj-art-fd1ecd1c9b2740959f7a98219333f6862025-02-03T01:05:19ZengWileyInternational Journal of Dentistry1687-87281687-87362021-01-01202110.1155/2021/88401678840167Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical TrialEnji Ahmed0Olfat G. Shaker1Nermin Yussif2Dalia M. Ghalwash3Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Giza, EgyptMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Giza, EgyptOral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Giza, EgyptDepartment of Oral Medicine and Periodontology, Faculty of Dentistry, The British University in Egypt, El Sherouk City, EgyptObjectives. Periodontitis is characterized by inflammatory destruction of periodontal tissue, loss of attachment, and bone resorption. The increase in reactive oxygen species (ROS) is responsible for the oxidative damage occurring in periodontal tissues. Melatonin has important immunomodulatory, anti-inflammatory, and powerful antioxidant functions. The current study was carried out to evaluate the effect of topical melatonin gel as an adjunct to nonsurgical periodontal therapy. Methods. This split-mouth randomized controlled clinical trial was performed on 24 patients with grade II periodontitis. Two sites in each patient were randomly assigned; test sites were treated by nonsurgical therapy followed by intrapocket application of 5% melatonin gel. Control sites were treated by nonsurgical therapy followed by intrapocket application of placebo gel. Both the melatonin and placebo gel were applied weekly once for four weeks. Assessment of clinical parameters (PD and CAL) was done at baseline and 3 months after therapy. Total antioxidative capacity (TAC) and matrix metalloproteinase-9 (MMP-9) levels in GCF were also evaluated utilizing commercially available enzyme-linked immunosorbent assay kits (ELISA) at baseline and 3 months after therapy. Results. Treatment with topical melatonin was associated with a reduction in periodontal inflammation reflected as an improvement in the clinical periodontal parameters. Melatonin-treated sites showed a more statistically significant percent reduction in PD and more statistically significant percent gain in CAL than the control site. Additionally, a significant increase in TAC and a significant decrease in MMP-9 levels in GCF were found in melatonin-treated sites in comparison to control sites. Conclusions. The adjunctive use of topical melatonin gel with nonsurgical periodontal therapy has potent anti-inflammatory and antioxidant activity in the treatment of grade II periodontitis patients.http://dx.doi.org/10.1155/2021/8840167
spellingShingle Enji Ahmed
Olfat G. Shaker
Nermin Yussif
Dalia M. Ghalwash
Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
International Journal of Dentistry
title Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
title_full Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
title_fullStr Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
title_full_unstemmed Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
title_short Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial
title_sort effect of locally delivered melatonin as an adjunct to nonsurgical therapy on gcf antioxidant capacity and mmp 9 in stage ii periodontitis patients a randomized controlled clinical trial
url http://dx.doi.org/10.1155/2021/8840167
work_keys_str_mv AT enjiahmed effectoflocallydeliveredmelatoninasanadjuncttononsurgicaltherapyongcfantioxidantcapacityandmmp9instageiiperiodontitispatientsarandomizedcontrolledclinicaltrial
AT olfatgshaker effectoflocallydeliveredmelatoninasanadjuncttononsurgicaltherapyongcfantioxidantcapacityandmmp9instageiiperiodontitispatientsarandomizedcontrolledclinicaltrial
AT nerminyussif effectoflocallydeliveredmelatoninasanadjuncttononsurgicaltherapyongcfantioxidantcapacityandmmp9instageiiperiodontitispatientsarandomizedcontrolledclinicaltrial
AT daliamghalwash effectoflocallydeliveredmelatoninasanadjuncttononsurgicaltherapyongcfantioxidantcapacityandmmp9instageiiperiodontitispatientsarandomizedcontrolledclinicaltrial